What is the CVSS score of CVE-2019-19382?

CVE-2019-19382 has a CVSS 3.1 base score of 7.8 (High). CVSS vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 0.5%.

Is there a public PoC exploit available for CVE-2019-19382?

Yes, a public proof-of-concept exploit is available for CVE-2019-19382. Prioritise patching immediately. EPSS: 0.5%.

Anti Virus Plus CVE-2019-19382

HIGH

Incorrect Permission Assignment for Critical Resource (CWE-732)

2019-12-03 cve@mitre.org

Privilege Escalation Anti Virus Plus

7.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

7.8 HIGH

AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Local

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Dec 03, 2019 - 20:15 nvd

HIGH 7.8

DescriptionNVD

Max Secure Anti Virus Plus 19.0.4.020 has Insecure Permissions on the installation directory. Local attackers can replace a .exe or .dll file to achieve privilege escalation.

AnalysisAI

Max Secure Anti Virus Plus 19.0.4.020 has Insecure Permissions on the installation directory. Rated high severity (CVSS 7.8), this vulnerability is low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified as Incorrect Permission Assignment (CWE-732), which allows attackers to access resources due to misconfigured permissions. Max Secure Anti Virus Plus 19.0.4.020 has Insecure Permissions on the installation directory. Local attackers can replace a .exe or .dll file to achieve privilege escalation. Affected products include: Maxpcsecure Anti Virus Plus.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Review and restrict file/resource permissions, apply principle of least privilege.